CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The Netherlands

GlobalData
175 Pages - GLDATA63042
$1,995.00

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The Netherlands". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in the Netherlands. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The value of the pharmaceuticals market decreased from $7.1 billion in 2009 to $5.3 billion in 2016 at a negative Compound Annual Growth Rate (CAGR) of 4%, and this value is expected to decrease further from $5.1 billion in 2017 to $4.3 billion in 2021 at a negative CAGR of 4%. The medical device market was worth $3.5 billion in 2016 and is projected to reach $4.3 billion by 2021 at a CAGR of 4%.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Netherlands, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Teva, Pfizer, Merck, Roche, and AbbVie; and of major players in the medical device market: Medtronic, Essilor, Roche, Zimmer Biomet, and Ethicon
- An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare environment, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Netherlands’ healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Netherlands’ healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Netherlands’ healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Executive Summary 7
3 Introduction 12
3.1 GlobalData Report Guidance 12
4 Overview of Pharmaceutical and Medical Device Markets 13
4.1 Pharmaceutical Market 13
4.1.1 Market Overview 13
4.1.2 Pharmaceutical Imports and Exports 16
4.1.3 Supply Channels 17
4.1.4 Market Segments 18
4.1.5 Overview of Major Therapeutic Areas 23
4.1.6 Major Players 25
4.2 Medical Device Market 61
4.2.1 Market Overview 61
4.2.2 Overview of Top Five Segments 63
4.2.3 Major Players 74
4.3 Market Drivers and Barriers 108
4.3.1 Drivers 108
4.3.2 Barriers 108
5 Market Access 110
5.1 Overview of Healthcare system 110
5.2 Reimbursement and Payer Landscape 111
5.3 Reimbursement Process 112
5.3.1 Overview of Insurance Providers 113
5.3.2 Patient Share in Healthcare Expenditure 115
5.3.3 Price Trends in the Healthcare Sector 116
5.3.4 Pricing Policies 117
5.4 Regulatory Landscape 118
5.4.1 Overview of Regulatory Agencies 118
5.4.2 Market Authorization Procedure for Pharmaceutical Products 118
5.4.3 Market Authorization Procedure for Medical Devices 125
5.4.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 130
5.4.5 Licensing Process for Pharmaceutical Exports and Imports 131
5.4.6 Intellectual Property Rights 132
5.4.7 Clinical Trial Regulations 136
5.4.8 Pharmaceutical Advertising Regulations 137
5.4.9 Pharmacy Regulations 138
5.4.10 Labeling and Packaging Regulations 138
6 Country Healthcare Landscape 140
6.1 Healthcare Policy Initiatives 140
6.2 Healthcare Infrastructure 141
6.2.1 Healthcare Facilities 141
6.2.2 Healthcare Parameters 143
6.2.3 Healthcare Personnel 151
6.2.4 Environmental Health 155
6.3 Healthcare Expenditure 157
6.3.1 Overview 157
6.3.2 Share of Public and Private Sectors 158
6.3.3 Major Components of Healthcare Expenditure 159
6.4 Trade Associations 160
6.4.1 Nefemed 160
6.4.2 Nefarma 160
6.4.3 Neprofarm 160
6.4.4 Diagned 160
6.5 Trade Fairs 161
7 Opportunities and Challenges 162
7.1 Opportunities 162
7.2 Challenges 162
8 Appendix 164
8.1 Abbreviations 164
8.2 Bibliography 167
8.3 Research Methodology 173
8.3.1 Coverage 173
8.3.2 Secondary Research 174
8.3.3 Forecasts 174
8.3.4 Expert Panel 174
8.4 Contact Us 175
8.5 Disclaimer 175

1.1 List of Tables
Table 1: Pharmaceutical Market, Netherlands, Revenue ($bn), 2009-2016 14
Table 2: Pharmaceutical Market, Netherlands, Revenue ($bn), 2017-2021 15
Table 3: Pharmaceutical Market, Netherlands, Imports and Exports ($bn), 2009-2016 16
Table 4: Pharmaceutical Market, Netherlands, EU Countries, Generic Drugs Market Share (Volume %), 2016 19
Table 5: Pharmaceutical Market, Netherlands, Biosimilars Approved and Marketed, 2012 20
Table 6: Pharmaceutical Market, Netherlands, OTC Drugs Market Sales ($m), 2011-2016 21
Table 7: Pharmaceutical Market, Netherlands, Major OTC Drug Class Market Share (%) and Revenue ($m), 2016 22
Table 8: Pharmaceutical Market, Netherlands, Expenditure on Major Medicine Groups ($m) and Share (%), 2013 23
Table 9: Pharmaceutical Market, Teva, Late-Stage Pipeline, 2017 26
Table 10: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2017 32
Table 11: Pharmaceutical Market, Merck, Global, Major Products, 2017 41
Table 12: Pharmaceutical Market, Merck, Global, Late-Stage Pipeline, 2017 42
Table 13: Pharmaceutical Market, Roche, Global, Revenue ($m) and Annual Growth (%) of Major Products, 2016 48
Table 14: Pharmaceutical Market, Roche, Global, Late-stage Pipeline, 2017 48
Table 15: Pharmaceutical Market, AbbVie, Europe, Late-Stage Pipeline, 2017 55
Table 16: Medical Device Market, Netherlands, Revenue ($bn), 2009-2016 61
Table 17: Medical Device Market, Netherlands, Revenue ($bn), 2017-2021 62
Table 18: Medical Device Market, Netherlands, Revenue ($m) and Market Share (%) by Segment, 2016 63
Table 19: Cardiovascular Device Market, Netherlands, Revenue ($m), 2009-2016 64
Table 20: Cardiovascular Device Market, Netherlands, Revenue ($m) and Market Share (%) of Major Players, 2016 65
Table 21: Ophthalmic Device Market, Netherlands, Revenue ($m), 2009-2016 66
Table 22: Ophthalmic Devices Market, Netherlands, Revenue ($m) and Market Share (%) of Major Players, 2015 67
Table 23: In Vitro Diagnostic Market, Netherlands, Revenue ($m), 2009-2017 68
Table 24: In Vitro Diagnostic Market, Netherlands, Revenue ($m) and Market Share (%) of Major Players, 2017 69
Table 25: Orthopedic Device Market, Netherlands, Revenue ($m), 2009-2016 70
Table 26: Orthopedic Device Market, Netherlands, Revenue ($m) and Market Share (%) of Major Players, 2016 71
Table 27: Wound Care Management Market, Netherlands, Revenue ($m), 2009-2017 72
Table 28: Wound Care Management Market, Netherlands, Revenue ($m) and Market Share (%) of Major Players, 2017 73
Table 29: Major Players, Netherlands, Revenue ($m), 2016 74
Table 30: Medical Device Market, Medtronic, Global, Major Products, 2017 76
Table 31: Medical Device Market, Essilor, Netherlands, Major Products, 2017 86
Table 32: Medical Device Market, Roche, Netherlands, Major Products, 2017 91
Table 33: Medical Device Market, Zimmer Biomet, Global, Major Products, 2017 98
Table 34: Medical Device Market, Ethicon, Major Products, 2017 103
Table 35: Healthcare Expenditure, Netherlands, Out-of-Pocket Expenditure (%), 2009-2016 116
Table 36: Market Access, Netherlands, Consumer Price Index Annual Change (%), 2009-2015 117
Table 37: Healthcare Infrastructure, Netherlands, Hospitals, 2009-2016 141
Table 38: Healthcare Infrastructure, Netherlands, Diagnostic Units, 2009-2016 142
Table 39: Healthcare Infrastructure, Netherlands, Hospitals Beds (per 1,000 population), 2009-2016 143
Table 40: Demographics, Netherlands, Life Expectancy at Birth (years), 2009-2016 144
Table 41: Demographics, Netherlands, Life Expectancy at Birth (years), 2017-2021 145
Table 42: Demographics, Netherlands, Immunization Rate (%), 2009-2016 146
Table 43: Demographics, Netherlands, Major Causes of Mortality (number of deaths), 2015 147
Table 44: Demographics, Netherlands, Major Causes of Male Mortality (number of deaths), 2015 148
Table 45: Demographics, Netherlands, Major Causes of Female Mortality (number of deaths), 2015 149
Table 46: Demographics, Netherlands, Disability-Adjusted Life Years by Major Disease (‘000), 2015 150
Table 47: Healthcare Infrastructure, Netherlands, Doctors (per 1,000 population), 2009-2016 151
Table 48: Healthcare Infrastructure, Netherlands, Nurses (per 1,000 population), 2009-2016 152
Table 49: Healthcare Infrastructure, Netherlands, Dentists (per 1,000 population), 2009-2016 153
Table 50: Healthcare Infrastructure, Netherlands, Pharmacists (per 1,000 population), 2009-2016 154
Table 51: Healthcare Infrastructure, Netherlands, PM2.5 (µg per m³), 2009-2016 155
Table 52: Healthcare Infrastructure, Netherlands, CO2 Emissions (kilotons), 2009-2016 156
Table 53: Healthcare Expenditure, Netherlands, Healthcare Expenditure (% of GDP), 2009-2016 157
Table 54: Healthcare Expenditure, Netherlands, Public-Private Share of Expenditure (%), 2009-2016 158
Table 55: Healthcare Expenditure, Netherlands, Major Components of Healthcare Expenditure (%), 2016 159
Table 56: Healthcare Expenditure, Netherlands, Major Healthcare Trade Fairs, 2017 161

1.2 List of Figures
Figure 1: Pharmaceutical Market, Netherlands, Revenue ($bn), 2009-2021 8
Figure 2: Medical Device Market, Netherlands, Revenue ($bn), 2009-2021 9
Figure 3: Country Profile, Netherlands, 2017 11
Figure 4: Pharmaceutical Market, Netherlands, Revenue ($bn), 2009-2016 14
Figure 5: Pharmaceutical Market, Netherlands, Revenue ($bn), 2017-2021 15
Figure 6: Pharmaceutical Market, Netherlands, Imports and Exports ($bn), 2009-2016 16
Figure 7: Pharmaceutical Market, Netherlands, Distribution Channels, 2016 18
Figure 8: Pharmaceutical Market, Netherlands, EU Countries, Generic Drugs Market Share (%), 2016 19
Figure 9: Pharmaceutical Market, Netherlands, OTC Drugs Market Sales ($m), 2011-2016 21
Figure 10: Pharmaceutical Market, Netherlands, Major OTC Drug Class Market Share (%), 2016 22
Figure 11: Pharmaceutical Market, Netherlands, Expenditure on Major Medicine Groups ($m), 2013 23
Figure 12: Medical Device Market, Netherlands, Revenue ($bn), 2009-2016 61
Figure 13: Medical Device Market, Netherlands, Revenue ($bn), 2017-2021 62
Figure 14: Medical Device Market, Netherlands, Revenue by Segment ($m), 2016 63
Figure 15: Cardiovascular Device Market, Netherlands, Revenue ($m), 2009-2016 64
Figure 16: Cardiovascular Device Market, Netherlands, Market Share of Major Players (%), 2016 65
Figure 17: Ophthalmic Device Market, Netherlands, Revenue ($m), 2009-2016 66
Figure 18: Ophthalmic Device Market, Netherlands, Market Share of Major Players (%), 2015 67
Figure 19: In Vitro Diagnostic Market, Netherlands, Revenue ($m), 2009-2017 68
Figure 20: In Vitro Diagnostic Market, Netherlands, Market Share of Major Players (%), 2017 69
Figure 21: Orthopedic Device Market, Netherlands, Revenue ($m), 2009-2016 70
Figure 22: Orthopedic Device Market, Netherlands, Market Share of Major Players (%), 2016 71
Figure 23: Wound Care Management Market, Netherlands, Revenue ($m), 2009-2017 72
Figure 24: Wound Care Management Market, Netherlands, Market Share of Major Players (%), 2017 73
Figure 25: Major Players, Netherlands, Revenue ($m), 2016 74
Figure 26: Healthcare Market, Netherlands, Drivers and Barriers, 2017 109
Figure 27: Market Access, Netherlands, Organizational Structure of Healthcare System, 2016 111
Figure 28: Market Access, Netherlands, Drug Reimbursement Process, 2014 112
Figure 29: Market Access, Netherlands, Structure of Health Insurance, 2016 113
Figure 30: Healthcare Expenditure, Netherlands, Out-of-Pocket Expenditure (%), 2009-2016 116
Figure 31: Market Access, Netherlands, Consumer Price Index Annual Change (%), 2009-2015 117
Figure 32: Market Access, EU, Centralized Procedure, Market Authorization, Pre-submission Phase, 2017 120
Figure 33: Market Access, EU, Centralized Procedure, Market Authorization, Pre-opinion Phase, 2017 122
Figure 34: Market Access, EU, Centralized Procedure, Market Authorization, Post-opinion Phase, 2017 123
Figure 35: Market Access, EU, Decentralized Procedure, Market Authorization, 2017 124
Figure 36: Market Access, EU, Conformity Assessment of Class I Medical Devices, 2017 127
Figure 37: Market Access, EU, Conformity Assessment of Class IIa Medical Devices, 2017 128
Figure 38: Market Access, EU, Conformity Assessment of Class IIb Medical Devices, 2017 129
Figure 39: Market Access, EU, Conformity Assessment of Class III Medical Devices, 2017 130
Figure 40: Market Access, Netherlands, Patent Approval Process, 2016 134
Figure 41: Healthcare Infrastructure, Netherlands, Hospitals, 2009-2016 141
Figure 42: Healthcare Infrastructure, Netherlands, Diagnostic Units, 2009-2016 142
Figure 43: Healthcare Infrastructure, Netherlands, Hospitals Beds (per 1,000 population), 2009-2016 143
Figure 44: Demographics, Netherlands, Life Expectancy at Birth (years), 2009-2016 144
Figure 45: Demographics, Netherlands, Life Expectancy at Birth (years), 2017-2021 145
Figure 46: Demographics, Netherlands, Immunization Rate (%), 2009-2016 146
Figure 47: Demographics, Netherlands, Major Causes of Mortality (number of deaths), 2015 147
Figure 48: Demographics, Netherlands, Major Causes of Male Mortality (number of deaths), 2015 148
Figure 49: Demographics, Netherlands, Major Causes of Female Mortality (number of deaths), 2015 149
Figure 50: Demographics, Netherlands, Major Diseases, Disability-Adjusted Life Years by Major Disease (‘000s), 2015 150
Figure 51: Healthcare Infrastructure, Netherlands, Doctors (per 1,000 population), 2009-2016 151
Figure 52: Healthcare Infrastructure, Netherlands, Nurses (per 1,000 population), 2009-2016 152
Figure 53: Healthcare Infrastructure, Netherlands, Dentists (per 1,000 population), 2009-2016 153
Figure 54: Healthcare Infrastructure, Netherlands, Pharmacists (per 1,000 population), 2009-2016 154
Figure 55: Healthcare Infrastructure, Netherlands, PM2.5 (µg per m³), 2009-2016 155
Figure 56: Healthcare Infrastructure, Netherlands, CO2 Emissions (kilotons), 2009-2016 156
Figure 57: Healthcare Expenditure, Netherlands, Healthcare Expenditure (% of GDP), 2009-2016 157
Figure 58: Healthcare Expenditure, Netherlands, Public-Private Share of Expenditure (%), 2009-2016 158
Figure 59: Healthcare Expenditure, Netherlands, Major Components of Healthcare Expenditure (%), 2016 159
Figure 60: Healthcare Market, Netherlands, Opportunities and Challenges, 2017 163

$1,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports